Birla Fertility & IVF Expands to Mumbai, Plans Four More Centres in the City
by Prashant Kapadia/NHN
Mumbai, 18 February 2025: Birla Fertility & IVF, India’s third-largest IVF network, has launched its first centre in Mumbai, further strengthening its presence in Maharashtra. Conveniently located in Prabhadevi, near Siddhivinayak Temple, the centre ensures easy access to advanced fertility care.
The centre was formally inaugurated by renowned IVF specialist and Chief Guest, Dr. Hrishikesh Pai, in the presence of Birla Fertility & IVF’s Chief Executive Officer, Abhishek Aggrawal; Centre Head, Dr. Navina Singh, and other dignitaries, with a traditional lamp-lighting ceremony.
As part of its expansion strategy in Maharashtra, four more centres are set to open in Mumbai over the next 8–12 months with one existing centre at Nagpur. Beyond Mumbai, new centres are planned in Pune and Nashik, further strengthening access to expert-led fertility care across the region.
Birla Fertility & IVF is part of the CK Birla Group, a USD 3 billion diversified conglomerate with a 150-year legacy. The Group has a strong presence in healthcare, technology, and manufacturing, built on trust, medical excellence, and innovation. With over 50 clinics across 37 cities and 18 states, Birla Fertility & IVF is rapidly expanding, bringing clinically advanced and patient-centric fertility care closer to those who need it.
Infertility is a growing concern, with an estimated 28 million couples in India facing challenges in conceiving. The demand for specialised fertility treatments is rising, yet access to affordable, high-quality reproductive care remains a barrier for many. Birla Fertility & IVF is committed to offering comprehensive fertility solutions, combining advanced treatments with affordability and accessibility.
As part of this commitment, one of the key initiatives focuses on making fertility preservation more financially accessible. Egg freezing, which has traditionally been considered expensive, is now available with structured payment options starting at just INR 1,666 per month. This initiative ensures that individuals can plan their reproductive future with greater confidence and ease.
Abhishek Aggrawal, Chief Executive Officer, Birla Fertility & IVF, said:”Our mission is to make high-quality, affordable, and comprehensive fertility and reproductive health solutions accessible across India. In addition to fertility treatments, we provide specialised care for PCOS, sexual health concerns, and cervical health, ensuring holistic support at every stage of an individual’s reproductive journey. Our goal of operating 100+ centres with an investment of INR 500 crores in the next few years is well on track.”
“Mumbai is a major hub, and this centre is a key milestone in our expansion. With additional centres planned in Pune and Nashik, we are committed to making fertility care more accessible across Maharashtra.
“The National Family Health Survey (2019-21) revealed that 29 of India’s 36 states have a fertility rate below 2. Maharashtra’s fertility rate stands at 1.7, while India’s total fertility rate (TFR) has dropped to 2.0, below the replacement threshold of 2.1. These trends have long-term implications for workforce dynamics and economic growth. Birla Fertility & IVF aims to bridge this gap by providing quality fertility treatment and evidence-based information, empowering individuals to make informed reproductive health decisions.
Dr. Navina Singh, Centre Head – Mumbai, Birla Fertility & IVF, said:”Infertility is becoming more common in urban areas due to high-stress lifestyles, delayed parenthood, and environmental factors. Every fertility journey is unique and requires a personalised approach. With advanced technology and tailored treatment options, including egg freezing, we are committed to making high-quality fertility care more accessible. This new centre will support individuals in making informed reproductive choices.”
The Mumbai clinic is equipped with state-of-the-art embryology labs and a dedicated team of fertility specialists. It offers a full spectrum of reproductive health services, including IVF, IUI, fertility preservation (egg & sperm freezing), Preimplantation Genetic Testing (PGT), male fertility treatments, advanced genetic screening, and specialised care for PCOS and cervical health.
With a patient-first approach, transparent pricing, and clinically reliable outcomes, Birla Fertility & IVF continues to redefine fertility care in India.
About Birla Fertility & IVF : Birla Fertility & IVF, a CK Birla Healthcare company, is part of the USD 3 billion CK Birla Group. CK Birla Healthcare operates CK Birla Hospital a nation-wide chain of multi-disciplinary hospitals and Birla Fertility & IVF, a comprehensive fertility solutions company. It started its operations in 2020, and in just over 4 years of its launch, it has expanded its network to 50 centres across 37 cities and 18 states.
With its proposition of ‘All Heart, All Science,’ Birla Fertility & IVF brings care into the science of conception. It is committed to transforming the future of fertility globally, through best-in-class services, most clinically reliable outcomes and compassionate care.
Birla Fertility & IVF offers comprehensive and specialised fertility treatments like in-vitro fertilisation (IVF), Intracytoplasmic-Sperm Injection (ICSI), Intrauterine Insemination (IUI), Frozen Embryo Transfer (FET), Blastocyst Culture, Male and Female Infertility treatments, Cancer Fertility Preservation, Preimplantation Genetic Screening (PGS) and Preimplantation Genetic Diagnosis (PGD).
Birla Fertility & IVF has been recognized with several prestigious accolades, including the FICCI Healthcare Excellence Award in the category of Patient Safety and Care, the IHW Silver Award for Excellence in ART & IVF 2024, and the ET Healthworld.com National Fertility Awards 2024, where it was honoured as IVF/Fertility Chain of the Year (East) and IVF Clinic of the Year (East) for its unparalleled services and contributions to the field.
About CK Birla Group : The CK Birla Group, with a revenue of over US $3 billion, is an Indian multinational conglomerate. With over 35,000 employees, the group operates 52 manufacturing facilities across India and the world, with a presence in diverse sectors including technology, automotive, home and building, and healthcare.
The CK Birla Group continuously adapts to stay ahead in a changing world. By harnessing technology and investing in people and digital transformation, the Group consistently remains agile and delivers profitable growth. Viewing value creation through a global lens, our companies operate without borders.
The CK Birla Group companies include Birlasoft Limited, GMMCO Limited, National Engineering Industries Limited (manufacturer of NBC Bearings), Orient Cement Limited, HIL Limited, Orient Electric Limited, CK Birla Healthcare Private Limited (CK Birla Hospitals and Birla Fertility & IVF), Orient Paper & Industries Limited, AVTEC Limited and Neosym Industry Limited.